Atypical protein kinase Cι is an oncogene in human non-small cell lung cancer

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8905-8911

  Regala, Roderick P ^a   Weems, Capella ^a   Jamieson, Lee ^a   Khoor, Andras ^a   Edell, Eric S ^b   Lohse, Christine M ^b   Fields, Alan P ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C; PROTEIN KINASE C IOTA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; FEMALE; GENE AMPLIFICATION; GENE DISRUPTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION; ONCOGENE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE AMPLIFICATION; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; ONCOGENES; PROTEIN KINASE C;

EID: 25444531988     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2372     Document Type: Article

References (32)

1. American Cancer Society. Surveillance research cancer statistics. Atlanta: American Cancer Society; 2004.
2. Schiller JH. Current standards of care in small-cell and non-small-cell lung cancer. Oncology 2001;61 Suppl 1:3-13.
3. Minna JD, Gazdar AF. Translational research comes of age. Nat Med 1996;2:974-5.
4. Gazdar AF, Minna JD. Molecular detection of early lung cancer. J Natl Cancer Inst 1999;91:299-301.
5. Salgia R, Skarin AT. Molecular abnormalities in lung cancer. J Clin Oncol 1998;16:1207-17.
6. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, Testa JR. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 1997;57:2116-20.
7. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y. Protein kinase C ζ subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci U S A 1989;86:3099-103.
8. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-5.
9. Moscat J, Diaz-Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 2000;1:399-403.
10. Suzuki A, Akimoto K, Ohno S. Protein kinase C λ/ι (PKCλ/ι): a PKC isotype essential for the development of multicellular organisms. J Biochem (Tokyo) 2003;133:9-16.
11. Jamieson L, Carpenter L, Biden TJ, Fields AP. Protein kinase Cι activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J Biol Chem 1999;274:3927-30.
12. Murray NR, Fields AP. Atypical protein kinase Cι protects human leukemia cells against drug-induced apoptosis. J Biol Chem 1997;272:27521-4.
13. Etienne-Mannevule S, Hall A. Cell polarity: Par6, aPKC and cytoskeletal crosstalk. Curr Opin Cell Biol 2003;15:67-72.
14. Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT, Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J 1999;18:3044-53.
15. Wang CY, Guttridge DC, Mayo MW Baldwin AS, Jr. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999;19:5923-9.
16. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-3.
17. Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP. Atypical protein kinase Cι plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem. Epub 2005 July 1.
18. Bible KC, Boerner SA, Kaufmann SH. A one-step method for protein estimation in biological samples: nitration of tyrosine in nitric acid. Anal Biochem 1999;267:217-21.
19. Murray NR, Jamieson L, Yu W, et al. Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol 2004;164:797-802.
20. Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP. Protein kinase C βII induces cell invasion through a Ras/MEK-, PKCι/RAC 1-dependent signaling pathway. J Biol Chem 2004;279:22118-23.
21. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. 1st ed. Ann Arbor: Springer-Verlag; 2000.
22. Pastorino U, Andreola S, Tagliabue E, et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 1997;15:2858-65.
23. Brass N, Racz A, Heckel D, Remberger K, Sybrecht GW, Meese EU. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res 1997;57:2290-4.
24. Yokoi S, Yasui K, Iizasa T, Imoto I, Fujisawa T, Inazawa J. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin Cancer Res 2003;9:4705-13.
25. Imoto I, Pimkhaokham A, Fukuda Y, et al. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 2001;286:559-65.
26. Singh B, Reddy PG, Goberdhan A, et al. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 2002;16:984-93.
27. Osada H, Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2002;21:7421-34.
28. Snaddon J, Parkinson EK, Craft JA, Bartholomew C, Fulton R. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 2001;84:1630-4.
29. Pimkhaokham A, Shimada V, Fukuda Y, et al. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon. Jpn J Cancer Res 2000;91:1126-33.
30. Sugita M, Tanaka N, Davidson S, et al. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 2000;117:9-18.
31. Sonoda G, Palazzo J, du Manoir S, et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 1997;20:320-8.
32. Lu Y, Jamieson L, Brasier AR, Fields AP. NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival. Oncogene 2001;20:4777-92.